A study evaluating safety and efficacy of Lenvatinib in advanced radioiodine-refractory thyroid cancer patients
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 07 Mar 2018 New trial record
- 01 Mar 2018 Results published in the Anticancer Research